Ultra-sensitive Proteomics Will Revolutionize Early Disease Detection Worldwide
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
08 Aug 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
US$18.00
74.8% undervalued intrinsic discount08 Aug
US$4.54
1Y
-60.0%7D
-17.6%